12183251.txt 0 application   realtime pcr   determination   antiviral drug susceptibility   herpes simplex virus
12183251.txt 1   quantitative realtime pcr taqman assay was developed   determination   antiviral drug susceptibility   herpes simplex virus hsv after shorttime culture     virus   antiviral drug susceptibility   hsv isolates   acyclovir acv was determined   measuring   reduction     hsv type 1 hsv1 dna levels   culture supernatants using realtime pcr   50 inhibitory concentration was reported     concentration   antiviral drug   reduced   number   hsv1 dna copies   50   total   15 wellcharacterized acvsensitive   resistant strains   clinical isolates were used   assay evaluation   new assay   realtime pcr readout permitted rapid 3 days objective   reproducible determination   hsv1 drug susceptibilities     need   stringent control   initial multiplicity   infection furthermore   realtime pcr assay results showed   correlation r  086   those     plaque reduction assay   conclusion   realtime pcr assay described here     suitable quantitative method   determination   antiviral susceptibility   hsv1 amenable   use     routine diagnostic virology laboratory
12183251.txt 2 
12183251.txt 3 extensive use   acyclovir   other antiviral drugs   prophylaxis   treatment   herpes simplex virus hsv infections exerts   continuous selection pressure     hsv virus population hsv antiviral drug resistance occurs relatively frequently especially   immunocompromised patients such   those undergoing bone marrow 6   12   solid organ transplantation similar4   aids patients similar6   can   associated   serious disease  b lina   thouvenot c danve f morfin   boucher   berlin   m aymard abstract   european virology 2000 j clin virol 1847 2000   frequency   hsvresistant infections may increase because     increasing number   severely immunocompromised patients   chronic   recurrent hsv infections who require prolonged administration   antiviral drugs     patient group susceptibility testing   needed   detect drugresistant hsv strains     reconsider   antiviral treatment  f morfin   thouvenot g souillet m michallet   m aymard abstract   progress   clinical virology v acta microbiol immunol hung 46429 1999 safrin et al  has shown     correlation between   failure   hsv suppression   acyclovir acv   vivo     determination   acv resistance   vitro these observations emphasized   clinical relevance   antiviral resistance determination     laboratory several phenotypic assays have been described   some   them   used   clinical practice     plaque reduction assay pra     most frequently used drug susceptibility assay although   technique   laborious   timeconsuming   still remains   gold standard method     other tests   evaluated    majority   alternative susceptibility assays   based   reduction   cytopathic effect cpe     either microscopically evaluated   colorimetrically detected  assays based   enzymelinked immunosorbent assay elisa include   sandwich elisa      microplate  situ elisa misetest    latter has been shown   correlate well   pra other currently used antiviral susceptibility assays involve   use   dna hybridization  flow cytometric analysis    transgenic hsv inducible reporter cells      increasing numbers   immunocompromised individuals       need     widespread routine availability   antiviral drug susceptibility assays   would   rapid reproducible   clinically relevant currently used methods except     misetest suffer   certain pitfalls   preclude their routine use most     assays   timeconsuming   laborintensive some may have subjective endpoints require special equipment   trained laboratory personnel therefore   set out   develop an assay   would overcome most     aforementioned restrictions   could   easily implemented     diagnostic laboratory   describe   development   evaluation     new approach   hsv1 drug susceptibility determination using quantitative realtime pcr taqman   measure viral dna production
12183251.txt 4 cells   viruses  vero cells african green monkey kidney were propagated   maintained   iscoves modified dulbeccos medium life technologies breda   netherlands supplemented   5 fetal bovine serum   gentamicin 10 mugml life technologies breda   netherlands   stock   hsv1 strain mcintyre counted   electron microscopy em was obtained   advanced biotechnologies inc columbia md   hsv1 strain kos     kosderived acvresistant mutants araar7 araar8 araar13 f891c pfar5   paar5  were kindly provided     m coen harvard medical school boston mass   hsv1 acvsensitive strains mcintyre   r39 were generously provided     linde swedish institute   infectious disease control solna sweden wellcharacterized acvresistant clinical isolates hsv 9825733ma3 hsv 9815779va2   hsv 9814742pe1 morfin et al acta microbiol immunol hung 46429 1999 were   gift   m aymard universite claude bernard lyon france other hsv1 clinical isolates were selected     own collection two originated   patients after bone marrow transplantation who had recurrent hsv infections   responding   acv   one was obtained     patient   oral hsv infection   resolved spontaneously virus stocks were grown   vero cells     infectious titer was determined   plaque assay   vero cells   previously described   schaffer et al   realtime pcr assay   hsv1 assay setup  hsv1specific pcr primers     fluorescent probe directed     hsv1 glycoprotein g gg gene were used   realtime pcr analysis   described   ryncarz et al  each 25 mul   pcr mixture contained 7 mul     1100diluted culture supernatant 900 nm concentrations   both forward   reverse primer   150 nm probe amplification was performed using   applied biosystems sequence detector 7700 under   following conditions incubation   2 min   50c       10 min   95c followed   45 cycles   15 s   95c   1 min   60c each pcr run contained two negative controls     dilution series   hsv1 dna 6 x 102   6 x 108 copiesml derived   emcounted virus stock hsv1 mcintyre   was used   generate   standard curve each sample was analyzed   duplicate  assay optimization    kinetics   hsv1 dna replication was examined   measuring   time course   increase   hsv1 dna yield   cell culture supernatants vero cells   24well culture plates were infected     multiplicity   infection moi   01 001   0001 pfucell   hsv1 strain mcintyre   development   cpe was monitored     levels   hsv1 dna were measured   realtime pcr   supernatant samples collected   12h intervals after infection experiments were also performed   evaluate   effect   acv     cell culture supernatant   pcr efficiency virus infected cell cultures moi 001 were incubated     without   high concentration   acv 48 mugml   48 h   resemble   conditions     assay described here subsequently cell culture supernatants were collected   spiked   hsv1 dna these spiked samples were amplified using   realtime pcr assay either   undiluted supernatant       dilution series   effect     moi     acv ic50s was determined   parallel experiments     cell cultures were infected     halflog10 incremental range   infectious doses moi 0001   05 pfucell   hsv1     presence   serial concentrations   acv   levels   hsv1 dna were measured   realtime pcr   supernatant samples collected   24 48   72 h postinfection     50 inhibitory concentrations ic50s were determined   cpe     virus control was scored     time   supernatant collection  realtime pcr assay   hsv1 antiviral susceptibility testing final setup  virus isolates   an moi   001 50 mul were dispensed   duplicate into wells     24well culture plate containing 450 mul   culture medium   different concentrations   acv     suspension   vero cells 6 x 105 cellsml serial twofold dilutions   acv sigma zwijndrecht   netherlands ranging   006   32 mugml were used plates were incubated   37c   2 days   monitored   development   cpe when complete cpe was reached   control wells 300 mul   culture supernatants was collected cleared   centrifugation 1100 x g 1 min 4c   examined   realtime pcr   stored   70c until assayed reference acvsusceptible kos   acvresistant araar8 strains were included   controls   each pcr assay   ic50 was used   express virus drug susceptibility   was defined     concentration   antiviral drug   reduced   number   dna copies   50 relative      drug virus control  pra    pra   drug susceptibility determination was performed   previously described   erlich et al    minor modifications using neutral red staining   plaque detection briefly confluent vero cell monolayers   24well culture plates were inoculated   40   60 pfu   virus after incubation   37c   1 h   viral inoculum was replaced   culture medium containing various concentrations   acv   05 agar   same acv concentrations were used       realtime pcr assay each drug concentration was tested   quadruplicate   plates were incubated   37c   2   3 days until plaques were observed     control wells without   drug subsequently   monolayers were stained overnight using   second overlay medium containing 008 neutral red   08 agar   same reference control strains were used   each pra   were used       realtime pcr assay   ic50 was defined     acv concentration   reduced   number   plaques   50 compared     untreated control wells isolates were considered resistant   acv   ic50   2 mugml  statistical analysis  results   realtime pcr assay   pra were analyzed   compared using wilcoxons signed rank test   spearmans correlation coefficient
12183251.txt 5   goal was   develop an easy perform assay   hsv antiviral susceptibility testing suitable   implementation into   modern routine diagnostic laboratory   determine   optimize its characteristics several parameters     assay were studied   detail such     viral replication kinetics   effect   acv   culture supernatant   pcr efficiency     effect   moi   incubation time   drug susceptibility values once   optimal format     assay was set   test was validated     panel   wellcharacterized hsv1 strains   clinical isolates   sensitivity     realtime taqman pcr   detect hsv dna was evaluated   using serial dilution   hsv1 dna extracted   emcounted virus stock mcintyre   quantification was linear over   range   concentrations examined     least 107   1000 dna copies per ml kinetics   hsv1 dna replication  complete cpe was observed   36 48   60 h after infection     cultures infected   an moi   01 001   0001 pfucell respectively   corresponded   an hsv1 dna yield     culture supernatant   approximately 9 log10 copiesml culture wells showing less than 30 cpe were found   have dna levels     detection limit     realtime pcr assay   effect   acv   culture supernatant   performance   realtime pcr  using   viral culture supernatant directly     pcr analysis may introduce inhibitory substances     pcr particularly   presence   acv       dna polymerase inhibitor   culture supernatants could inhibit   pcr    presence   acv   48 mugml     cell culture supernatants decreased   yield   amplified products approximately sixfold   inhibitory effect   acv was completely overcome   diluting   cell culture supernatant 100fold   water prior   pcr   was routinely done   later experiments  effect   moi   incubation time   ic50    ic50s   acv     taqman pcr assay   different mois   incubation times varied between 016   061 mugml  only   slight increase   ic50s   higher mois was observed   each time point   24 48   72 h   incubation respectively   maximum 18 32   21fold difference   ic50 was observed among   cultures infected     large range   mois   0001   05 pfucell   each moi an increase   ic50   incubation time was observed    ic50s detected   48   72 h were   average 2   24fold higher than those determined   24 h after infection   ic50 results were comparable   each moi regardless   incubation time   long     susceptibility was determined when   cpe     virus control was between 50   100   same findings were obtained   drugresistant viruses data   shown based   these results an incubation time   48 h   an moi   001 pfucell were subsequently selected   routine use  antiviral susceptibility testing using realtime pcr assay    realtime pcrbased hsv1 drug susceptibility assay was evaluated   parallel   pra     pilot study   nine wellcharacterized acvsensitive   resistant laboratory strains   six clinical isolates  acv ic50s determined   realtime pcr assay correlated well   those   pra r  086 p  00001    addition   observed fold differences   drug susceptibility between   reference strain kos   each     tested strains were highly comparable between   two assays r  099 p  00001    absolute ic50s determined     realtime pcr assay were significantly lower p  00001 than those   pra     acvsensitive   resistant laboratory strains   clinical isolates    average difference   ic50s was 77fold range 41   150fold between   two assays  reproducibility    reproducibility     cycle threshold ct values used   ic50 calculation was assessed   two aliquots     same supernatant samples collected   drug treated   drug control wells during acv susceptibility testing   three random isolates   mean intraassay coefficient   variation calculated   replicate ct values was 071 range 007   18 indicating   high level   reproducibility   assess   interexperimental variability   ic50     hsv1 strain kos was determined   seven repeated experiments   resulted     mean ic50   015 mugml range 010   025 mugml standard deviation  006 mugml  fig 1  time course   changes     yield   hsv1 dna after infection   different mois pfucell time course   changes     yield   hsv1 dna after infection   different mois pfucell   dna levels were measured   culture supernatants   realtime pcr   percent values represent   percent cpe observed     wells     indicated     graph until   first time point     100 cpe was reached   each moi fig 2  fold differences   susceptibility ic50 between   reference strain kos   tested strains   determined   realtime pcr assay   pra r  0 fold differences   susceptibility ic50 between   reference strain kos   tested strains   determined   realtime pcr assay   pra r  099   trend line   aligned     correlation coefficient 10 table 1  effect   moi   incubation time   acv ic50   vero cells measured   realtime pcr assay hsv1 mclntyre table 2  acv ic50s   hsv1 strains determined   realtime pcr assay   plaque reduction assay
12183251.txt 6   realtime pcr assay described here could     basis     useful novel readout system   antiviral drug susceptibility determination   assay developed   evaluated   hsv1 may   generally applicable   other viruses   assay measures inhibition   hsv1 dna production   quantification   viral dna using   taqman technology whereas   classical pra   reduction   numbers   virus induced plaques   used   determine   antiviral effect     drug thus both assays measure   effect   viral replication though using different readout parameters   determination   these different parameters may explain   differences   absolute ic50s between   two assays moreover pra does   take into account   effect   antiviral agent     plaque size   pra   antiviral effect     drug   often manifested     decrease   plaque size without complete prevention   plaque formation  smaller plaques   drugtreated wells consist   lower numbers   virusinfected cells     counted equally   plaques   normal size   control wells   leads   overestimation   viral susceptibility   realtime pcr assay however measures   true reduction   viral dna production       basic mechanism underlying   antiviral effect     drug   such   realtime pcr assay may give   accurate estimation     effect     drug   viral replication     realtime pcrbased hsv1 drug susceptibility assay   effect     moi     acv susceptibility was limited   was demonstrated   only small differences   ic50 among   cultures infected     large range   mois 500fold difference   effect     moi was small   long     virus had   infected     cells an incubation time   48 h was routinely used     assay however considering   reported differences   growth rates   clinical isolates   cannot   excluded   longer incubation times     needed   particular isolates   reach sufficient amount   cpe 50 required   reproducible realtime pcr analysis therefore rather than harvesting   virus     fixed reading time   would recommend monitoring cpe   subsequent susceptibility testing   cpe levels ranging   50   100   realtime pcr assay was evaluated   testing 15 hsv1 strains   acv susceptibility     comparing   results   those     conventional pra   test showed   correlation   pra   ic50s   also   fold differences   susceptibility between   reference sensitive   tested strains highly correlated based     range   ic50s obtained   sensitive hsv strains   clinical isolates   cutoff value   03 mugml   acv was considered     discriminative concentration   sensitive   resistant strains     realtime pcr assay     better     accurate definition       vitro resistance threshold     assay   larger number   clinical isolates needs     analyzed nevertheless     threshold values defining sensitive   resistant virus can differ depending     assay utilized    folddifferences   drug susceptibility compared     reference strain may provide   relevant information   comparing results generated   different drug susceptibility assays    realtime pcr assay described here allows   rapid determination     acv susceptibility   hsv strains   test was only mildly affected   variation     moi while quite accurate titration     clinical isolate   required   pra   realtime pcr assay has an objective readout       reproducibility furthermore       rapid   easier   perform than   pra full susceptibility testing results     realtime pcr assay were obtained within 3 days   contrast     usual 4   6 days required   pra       considerable improvement     combination     technology already available   many routine diagnostic laboratories may render     useful test     clinical virology laboratory   present realtime pcrbased assays   increasingly implemented into diagnostic clinical virology because   their high sensitivity high throughput   ease   use format    realtime pcr assay described here uses   same pcr components     performed under   same standard amplification conditions     routinely used   detection   hsv   clinical specimens thus   assay fits   well   methods already available     clinical virology laboratory     such   could   easily implemented   many clinical laboratories   house availability   antiviral susceptibility testing would enable physicians   obtain results   drug susceptibility     clinically useful time frame   may help explaining therapeutic failure   patients   responding adequately   treatment   conclusion   demonstrated   realtime pcr assay     suitable method     determination   antiviral drug susceptibility   hsv1 application     assay   clinical practice needs     further evaluated
12183251.txt 7 
